Tumour extravasation of nanomedicine: The EPR and alternative pathways
Advanced Drug Delivery Reviews · 2023
DOI: 10.1016/j.addr.2023.114707 ↗Kurz gefasst
Editorial in der Zeitschrift Advanced Drug Delivery Reviews, 2023. Verfasst von Youqing Shen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, Key Laboratory of Biomass Chemical Engineering of Ministry of Educat…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang Universi…
- Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT, USA.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shen, Y., & Bae, Y. H. (2023). Tumour extravasation of nanomedicine: The EPR and alternative pathways. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2023.114707
Vancouver
Shen Y, Bae YH. Tumour extravasation of nanomedicine: The EPR and alternative pathways. Advanced Drug Delivery Reviews. 2023. doi:10.1016/j.addr.2023.114707
BibTeX
@article{Shen2023,
author = {Shen, Youqing and Bae, You Han},
title = {Tumour extravasation of nanomedicine: The EPR and alternative pathways},
journal = {Advanced Drug Delivery Reviews},
year = {2023},
doi = {10.1016/j.addr.2023.114707}
}
EUVIMED